Hartford Financial Management Inc. Abbott Laboratories Transaction History

Hartford Financial Management Inc.

  • $462 Million
  • Q4 2024

A detailed history of Hartford Financial Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Hartford Financial Management Inc. holds 47,484 shares of ABT stock, worth $6.13 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
47,484
Previous 48,580 2.26%
Holding current value
$6.13 Million
Previous $5.54 Million 3.03%
% of portfolio
1.16%
Previous 1.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
SELL
$111.93 - $119.39 $122,675 - $130,851
-1,096 Reduced 2.26%
47,484 $5.37 Million
Q3 2024

Oct 28, 2024
SELL
$100.07 - $118.13 $108,375 - $127,934
-1,083 Reduced 2.18%
48,580 $5.54 Million
Q2 2024

Aug 09, 2024
BUY
$100.73 - $112.44 $8,360 - $9,332
83 Added 0.17%
49,663 $5.16 Million
Q1 2024

Apr 24, 2024
SELL
$109.52 - $120.96 $61,878 - $68,342
-565 Reduced 1.13%
49,580 $5.64 Million
Q4 2023

Jan 29, 2024
BUY
$90.19 - $110.4 $20,112 - $24,619
223 Added 0.45%
50,145 $5.52 Million
Q3 2023

Oct 24, 2023
SELL
$95.53 - $114.62 $3,439 - $4,126
-36 Reduced 0.07%
49,922 $4.83 Million
Q2 2023

Jul 26, 2023
SELL
$100.78 - $112.29 $61,576 - $68,609
-611 Reduced 1.21%
49,958 $5.45 Million
Q1 2023

Apr 25, 2023
SELL
$96.86 - $114.01 $20,050 - $23,600
-207 Reduced 0.41%
50,569 $5.12 Million
Q4 2022

Feb 01, 2023
SELL
$95.06 - $111.52 $120,250 - $141,072
-1,265 Reduced 2.43%
50,776 $5.58 Million
Q3 2022

Oct 25, 2022
SELL
$96.76 - $112.03 $107,887 - $124,913
-1,115 Reduced 2.1%
52,041 $5.04 Million
Q2 2022

Jul 21, 2022
SELL
$102.07 - $123.37 $68,897 - $83,274
-675 Reduced 1.25%
53,156 $5.78 Million
Q1 2022

May 05, 2022
BUY
$114.02 - $139.04 $2,622 - $3,197
23 Added 0.04%
53,831 $6.37 Million
Q4 2021

Jan 27, 2022
SELL
$115.53 - $141.46 $21,835 - $26,735
-189 Reduced 0.35%
53,808 $7.57 Million
Q3 2021

Oct 29, 2021
SELL
$116.66 - $129.06 $11,782 - $13,035
-101 Reduced 0.19%
53,997 $6.38 Million
Q2 2021

Jul 27, 2021
SELL
$105.79 - $124.53 $40,094 - $47,196
-379 Reduced 0.7%
54,098 $6.27 Million
Q1 2021

Apr 14, 2021
SELL
$108.84 - $128.23 $3,809 - $4,488
-35 Reduced 0.06%
54,477 $6.53 Million
Q4 2020

Feb 03, 2021
SELL
$105.0 - $114.42 $26,670 - $29,062
-254 Reduced 0.46%
54,512 $5.97 Million
Q3 2020

Oct 16, 2020
SELL
$91.64 - $111.29 $14,937 - $18,140
-163 Reduced 0.3%
54,766 $5.96 Million
Q2 2020

Jul 23, 2020
SELL
$76.57 - $98.0 $134,303 - $171,892
-1,754 Reduced 3.09%
54,929 $5.02 Million
Q1 2020

May 01, 2020
SELL
$62.82 - $91.86 $362,659 - $530,307
-5,773 Reduced 9.24%
56,683 $4.47 Million
Q4 2019

Jan 28, 2020
SELL
$78.51 - $87.4 $116,194 - $129,352
-1,480 Reduced 2.31%
62,456 $5.43 Million
Q3 2019

Oct 28, 2019
SELL
$81.84 - $88.74 $201,244 - $218,211
-2,459 Reduced 3.7%
63,936 $5.35 Million
Q2 2019

Aug 01, 2019
BUY
$72.88 - $85.0 $5,466 - $6,375
75 Added 0.11%
66,395 $5.58 Million
Q1 2019

May 08, 2019
SELL
$66.22 - $80.06 $264 - $320
-4 Reduced 0.01%
66,320 $5.3 Million
Q4 2018

Feb 04, 2019
SELL
$65.56 - $74.27 $24,191 - $27,405
-369 Reduced 0.55%
66,324 $4.8 Million
Q3 2018

Nov 01, 2018
SELL
$60.81 - $73.36 $29,979 - $36,166
-493 Reduced 0.73%
66,693 $4.89 Million
Q2 2018

Aug 10, 2018
BUY
$57.57 - $63.54 $1.11 Million - $1.23 Million
19,336 Added 40.41%
67,186 $4.1 Million
Q1 2018

Apr 10, 2018
SELL
$56.27 - $63.62 $5,795 - $6,552
-103 Reduced 0.21%
47,850 $2.87 Million
Q4 2017

Jan 16, 2018
SELL
$53.68 - $57.47 $45,359 - $48,562
-845 Reduced 1.73%
47,953 $2.74 Million
Q3 2017

Oct 16, 2017
BUY
$48.06 - $53.64 $2.35 Million - $2.62 Million
48,798
48,798 $2.6 Million

Others Institutions Holding ABT

# of Institutions
3,230
Shares Held
1.3B
Call Options Held
8.71M
Put Options Held
8.03M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hartford Financial Management Inc. Portfolio

Follow Hartford Financial Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hartford Financial Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email